01 1Solara Active Pharma Sciences Limited
01 1Methohexital
01 1India
NDC Package Code : 72643-021
Start Marketing Date : 2020-03-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Methohexital manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Methohexital, including repackagers and relabelers. The FDA regulates Methohexital manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Methohexital API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Methohexital manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Methohexital supplier is an individual or a company that provides Methohexital active pharmaceutical ingredient (API) or Methohexital finished formulations upon request. The Methohexital suppliers may include Methohexital API manufacturers, exporters, distributors and traders.
click here to find a list of Methohexital suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Methohexital as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Methohexital API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Methohexital as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Methohexital and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Methohexital NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Methohexital suppliers with NDC on PharmaCompass.
We have 1 companies offering Methohexital
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
